Table 4 The joint effect of advanced airway and adrenaline on risk of ROCS, survival to admission, and survival to hospital discharge
Outcome | Group | Crude OR (95%CI) | P | Adjusted OR (95%CI) | P |
|---|---|---|---|---|---|
ROSC | Neither adrenaline nor AAM | reference | reference | ||
AAM and no adrenaline | 1.26 (0.64–2.45) | 0.504 | 1.36 (0.68–2.72) | 0.392 | |
Adrenaline and no AAM | 0.97 (0.52–1.81) | 0.920 | 1.04 (0.54–1.99) | 0.917 | |
Both adrenaline and AAM | 1.95 (1.16–3.28) | 0.011 | 2.14 (1.20–3.81) | 0.010 | |
Survival to admission | Neither adrenaline nor AAM | reference | reference | ||
AAM and no adrenaline | 1.21 (0.58–2.48) | 0.621 | 1.31 (0.62–2.77) | 0.476 | |
Adrenaline and no AAM | 0.95 (0.49–1.88) | 0.894 | 1.06 (0.53–2.13) | 0.865 | |
Both adrenaline and AAM | 1.89 (1.08–3.30) | 0.026 | 2.15 (1.16–3.97) | 0.015 | |
Survival to hospital discharge | Neither adrenaline nor AAM | reference | reference | ||
AAM and no adrenaline | 0.21 (0.03–1.61) | 0.135 | 0.19 (0.02–1.58) | 0.124 | |
Adrenaline and no AAM | NA | 0.994 | NA | 0.994 | |
Both adrenaline and AAM | 1.22 (0.52–2.83) | 0.647 | 1.33 (0.52–3.40) | 0.552 |